Steward Partners Investment Advisory’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Buy
9,896
+9,796
+9,796% +$353K ﹤0.01% 1739
2026
Q1
$2.45K Hold
100
– – ﹤0.01% 3997
2025
Q4
$2.48K Hold
100
– – ﹤0.01% 3903
2025
Q3
$2.83K Hold
100
– – ﹤0.01% 3822
2025
Q2
$2.49K Hold
100
– – ﹤0.01% 3691
2025
Q1
$3.1K Hold
100
– – ﹤0.01% 3532
2024
Q4
$3.15K Hold
100
– – ﹤0.01% 3507
2024
Q3
$5.79K Hold
100
– – ﹤0.01% 3139
2024
Q2
$4.06K Hold
100
– – ﹤0.01% 3112
2024
Q1
$4.2K Hold
100
– – ﹤0.01% 3094
2023
Q4
$3.83K Hold
100
– – ﹤0.01% 3063
2023
Q3
$3.08K Hold
100
– – ﹤0.01% 2975
2023
Q2
$3.16K Hold
100
– – ﹤0.01% 2935
2023
Q1
$3.65K Hold
100
– – ﹤0.01% 2887
2022
Q4
$2.96K Hold
100
– – ﹤0.01% 2931
2022
Q3
$4K Hold
100
– – ﹤0.01% 2889
2022
Q2
$4K Hold
100
– – ﹤0.01% 2878
2022
Q1
$5K Hold
100
– – ﹤0.01% 2915
2021
Q4
$7K Hold
100
– – ﹤0.01% 2745
2021
Q3
$9K Buy
+100
New +$8.5K ﹤0.01% 2648

Other funds holding ASTH

Steward Partners Investment Advisory's ASTH Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Astrana Health (ASTH) stake by 9,796% in Q2 2026, buying an estimated $353K and bringing the position to 9,896 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Steward Partners Investment Advisory first reported a position in ASTH in Q3 2021 and has held it in 20 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Steward Partners Investment Advisory held 9,896 shares of Astrana Health worth $459K as of Q2 2026.
  • Steward Partners Investment Advisory bought 9,796 Astrana Health shares in Q2 2026, an estimated $353K.
  • Astrana Health made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1739 holding.
  • Steward Partners Investment Advisory first reported a position in Astrana Health in Q3 2021 and has held it in 20 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.